A Figure 1 Podcast

Summary

For the full US Prescribing Information, click here.

For patients with hard-to-treat epilepsies, a syndrome-specific diagnosis is crucial to ensuring they receive the best possible care, including access to antiseizure medications (ASMs). But some epilepsies evolve and seem more elusive as patients reach adolescence or adulthood. In this final episode of the podcast series, epilepsy experts David Burdette, MD, and Ann Hyslop Segeren, MD, examine how a clear, clinical diagnosis can facilitate appropriate treatment regimens for pediatric and adult patients. They review consensus recommendations for identifying symptoms, navigating historical data, and utilizing resources developed by experts for use by healthcare providers in any diagnostic setting.

The basis of this series is a publication in the journal Epilepsia Open. This podcast is sponsored by Jazz Pharmaceuticals and is for US prescribers only. It is intended for informational purposes only and is not a substitute for clinical knowledge or professional judgment. Never disregard professional medical advice or delay in seeking it because of something you have read or heard on this podcast. Podcast presenters are paid consultants for Jazz Pharmaceuticals. There are no certified continued medical education credits approved for the podcast. ©2026 Jazz Pharmaceuticals plc or its subsidiaries. All rights reserved. US-EPX-2500227

David Burdette, MD, FACNS

Section Chief, Epilepsy, Spectrum Health Medical Group

David Burdette, MD, is board certified in neurology, epilepsy and clinical neurophysiology. Dr. Burdette serves as Section Chief, Epilepsy, Spectrum Health Medical Group. He earned his medical degree from Boston University School of Medicine and completed his neurology residency at Boston University Hospitals. Dr. Burdette completed clinical neurophysiology and epilepsy fellowships at University of Michigan Medical Center in Ann Arbor.

Ann Hyslop Segeren, MD

Pediatric Neurologist and Clinical Associate Professor, Stanford Medicine Children’s Health

Ann Hyslop Segeren, MD, is a board-certified pediatric neurologist. Dr. Hyslop Segeren graduated from the University of Texas Medical School at Houston, completed her pediatrics residency at The Mount Sinai Hospital in New York City, and did her neurology residency at the University of Washington and Seattle Children’s Hospital in Washington state. She completed a two-year clinical neurophysiology fellowship at Nicklaus Children’s Hospital with a focus on surgical epilepsy.